Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

Updated April 9th, 2020

Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

An impurity in the ingredient ranitidine has been found to increase cancer-risk over time. Find out what over-the-counter heartburn remedies you can safely take instead:

NOW
PLAYING
New Treatment Shows Huge Promise For Decreasing COVID Symptom-- Are Monoclonal Antibodies An Option for Cancer Patients?
NOW
PLAYING
Actress Kristen Bell, 40, Says "I’ve Been Struggling the Last 2 Weeks," Reminding Us Importance of Mental Health; Especially Critical For Those Fighting Cancer
NOW
PLAYING
Days After Giving Birth to Twins, New Mom, 26, Told She Has Incurable Breast Cancer
NOW
PLAYING
Dolly Parton's Rumored Cancer Turned Out to Be Kidney Stones; Is There a Link Between the Two Conditions?
NOW
PLAYING
Rocker Ozzy Osbourne Says Wife Sharon Told Him to Keep Performing During Her Colon Cancer Battle Because He 'Was Driving Her Nuts'
NOW
PLAYING
Actor Jeff Bridges, 70, Donates His “Finest Guitar” to Help Others Even as He Fights His Own Lymphoma Battle

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.